Active Ingredient: ATOVAQUONE; PROGUANIL HYDROCHLORIDE
Proprietary Name: ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 62.5MG;25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202362
Product Number: 001
Approval Date: May 27, 2014
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
Active Ingredient: ATOVAQUONE; PROGUANIL HYDROCHLORIDE
Proprietary Name: ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MG;100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202362
Product Number: 002
Approval Date: May 27, 2014
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information